When are drug ads to be believed and who is controlling their verbiage? It should be the job of the Food and Drug Administration (FDA), but how carefully is it overseeing drug studies versus mere puffery? Robert A. Clifford, founder and senior partner of Clifford Law Offices, examines some recent cases through the eyes of Prevagen, a highly advertised drug that touts memory improvement.
To read the column that appeared in the November-December issue of the Chicago Lawyer, click here.